Cardiovascular disease is both a risk factor and potential outcome of the direct, indirect and long-term effects of COVID-19. A range of cardiovascular (CV) abnormalities has been reported among patients beyond the acute phase. There are 19 long covid symptoms related to cardiovascular finding and symptoms are reported. We mapped these symptoms to Human Phenotype Ontology (HPO) terms.
LONG COVID – CARDIOVASCULAR
Cardiovascular Findings
Abnormal heart morphology (HP:0001627)
Abnormal heart rate variability (HP:0031860)
Abnormal left ventricular function (HP:0005162)
Abnormal pericardium morphology (HP:0001697)
Bradycardia (HP:0001662)
Hypertension (HP:0000822)
Hypotension (HP:0002615)
Increased circulating troponin T concentration (HP:0410174)
Increased circulating troponin I concentration (HP:0410173)
Myocarditis (HP:0012819)
Pericardial effusion (HP:0001698)
Reduced ejection fraction (HP:0012664)
Tachycardia (HP:0001649)
Venous thrombosis (HP:0004936)
Caridovascular Symptoms
Angina pectoris (HP:0001681)
Arrhythmia (HP:0011675)
Palpitations (HP:0001962)
Stroke (HP:0001297)
Syncope (HP:0001279)
